A new study says that postmenopausal women who regularly use aspirin and other analgesics have lower estrogen levels, which could contribute to a decreased risk of breast or ovarian cancer.
"We observed some significant inverse associations between concentrations of several estrogens and the use of aspirin, aspirin plus non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), and all analgesics combined," said Margaret A. Gates, Sc.D., research fellow at the Channing Laboratory at Brigham and Women's Hospital and Harvard Medical School.
"Our results suggest that among postmenopausal women, regular users of aspirin and other analgesics may have lower estrogen levels than non-users," Gates added.
These study results are published in Cancer Epidemiology, Biomarkers & Prevention
, a journal of the American Association for Cancer Research.
Gates and colleagues examined the association between use of aspirin, NSAIDs and acetaminophen and concentrations of estrogens and androgens among 740 postmenopausal women who participated in the Nurses' Health Study.
Frequency of all analgesic use was inversely associated with estradiol, free estradiol, estrone sulfate and the ratio of estradiol to testosterone.
Average estradiol levels were 10.5 percent lower among women who regularly used aspirin or non-aspirin NSAIDs. Similarly, free estradiol levels were 10.6 percent lower and estrone sulfate levels were 11.1 percent lower among regular users of aspirin or other NSAIDs. Among regular users of any analgesic (aspirin, NSAIDs or acetaminophen), levels of these hormones were 15.2 percent, 12.9 percent and 12.6 percent lower, respectively, according to Gates.